metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Oesophagogastric anastomosis complications in the Ivor Lewis operation
Journal Information
Vol. 89. Issue 3.
Pages 175-181 (March 2011)
Share
Share
Download PDF
More article options
Vol. 89. Issue 3.
Pages 175-181 (March 2011)
Original article
Full text access
Oesophagogastric anastomosis complications in the Ivor Lewis operation
Complicaciones de la anastomosis esofagogástrica en la operación de Ivor Lewis
Visits
3170
Álvaro Díaz de Liaño Argüellesa,*, Gustavo Sánchez Garcíab, Concepción Yárnoz Irazábala, Alicia Artajona Rosinoa
a Unidad Esófago-gástrica, Área de Cirugía, Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain
b Clínica Quirúrgica 2, Hospital Maciel, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
This item has received
Article information
Abstract
Introduction

Oesophagectomy is the principal treatment for cancer of the oesophagus. The oesophagogastric anastomotic leak is a serious complication of the Ivor Lewis operation, and is associated with increased mortality. The objective of this study is to analyse its incidence, its diagnosis and treatment results.

Material and methods

A descriptive analysis of a consecutive series of oesophagectomies, carried out during a 5 year period, using the Ivor Lewis technique. All patients had hand sewn anastomosis. Data were collected on general morbidity, anastomosis leak, hospital mortality, survival, and stenosis of the anastomosis.

Results

A total of 41 intrathoracic anastomoses were performed. Complications, of any type, were observed in 49% of cases, of which 3 (7.3%) were anastomotic leaks, one of them asymptomatic. One patient was urgently reoperated, and two others were treated with drains and conservative treatment. The mortality of the series was 7.3%, none associated with the anastomotic leak. The survival at 5 years was 27%, and 34% of the patients developed stenosis of the anastomosis.

Conclusions

Intrathoracic anastomosis after oesophagectomy, in our experience, can be performed with a low incidence of anastomotic leaks and without mortality due to this cause. Their treatment must be individualised and a considerable proportion do not require surgical intervention.

Keywords:
Oesophagectomy
Intrathoracic oesophagogastric
anastomosis
Anastomotic leak
Resumen
Introducción

La esofaguectomía es el principal tratamiento del cáncer de esófago. La dehiscencia de la anastomosis esofagogástrica es una complicación grave de la operación de Ivor Lewis que se asocia a una elevada mortalidad. El objetivo de este estudio es analizar su incidencia, su diagnóstico y los resultados del tratamiento.

Material y métodos

Análisis descriptivo de una serie consecutiva de esofaguectomías según la técnica de Ivor Lewis realizadas durante 5 años. Todas las anastomosis se realizaron de forma manual. Se registró la morbilidad general, dehiscencia de anastomosis, mortalidad intrahospitalaria, supervivencia y estenosis de la anastomosis.

Resultados

Se realizaron 41 anastomosis intratorácicas. Se presentaron complicaciones, de cualquier índole, en el 49% de los casos y se diagnosticaron 3 dehiscencias de la anastomosis (7,3%), una de ellas asintomática. Se reintervino de urgencia a un paciente, y los otros dos fueron tratados con drenajes y tratamiento conservador. La mortalidad de la serie fue del 7,3%, ninguna relacionada con la dehiscencia. La supervivencia a los 5 años fue del 27%. Un 34% de los pacientes desarrollaron estenosis de la anastomosis.

Conclusiones

La anastomosis intratorácica tras esofaguectomía puede realizarse, en nuestra experiencia, con una baja incidencia de dehiscencias y sin mortalidad por esta causa. El tratamiento de las mismas debe individualizarse y una parte considerable no precisa reintervención quirúrgica.

Palabras clave:
Esofaguectomía
Anastomosis esófago-gástrica
intratorácica
Dehiscencia
Full text is only aviable in PDF
References
[1.]
American Cancer Society.
Cancer Facts & Figuers 2009.
American Cancer Society, (2009),
[2.]
A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, et al.
Cancer Statistics, 2008.
CA Cancer J Clin, 58 (2008), pp. 71-96
[3.]
F. Kamangar, G.M. Dores, W.F. Anderson.
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world.
J Clin Oncol, 24 (2006), pp. 2137-2150
[4.]
J.F. Bosset, M. Gignoux, J.P. Triboulet, E. Tiret, G. Mantion, D. Elias, et al.
Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.
N Engl J Med, 337 (1997), pp. 161-167
[5.]
J. Tepper, M. Krasna, D. Niedzwiecki, D. Hollis, C. Reed, R. Goldberg, et al.
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy and surgery compared with surgery alone for esophageal cancer: CALGB 9781.
J Clin Oncol, 26 (2008), pp. 1086-1092
[6.]
R. Malthaner, R.K.S. Wong, R.B. Rumble, L. Zuraw.
Members of the Gastrointestinal Cancer Disease Site Group of Cancer Ontario's Program in Evidence-based Care. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.
BMC Medicine, 2 (2004), pp. 35
[7.]
B.P.L. Wijnhoven, J.J.B. Lanschot, H.W. Tilanus, E.W. Steyerberg, A. Van Der Gaast.
Neoadjuvant chemoradiotherapy for esophageal cancer: a review of meta-analyses.
World J Surg, 33 (2009), pp. 2606-2614
[8.]
R.H. Kim, K. Takabe.
Methods of esophagogastric anastomoses following esophagectomy for cancer: a systematic review.
J Surg Oncol, 101 (2010), pp. 527-533
[9.]
J.D. Mitchell.
Anastomotic leak after esophagectomy.
Thorac Surg Clin, (2006), pp. 1-9
[10.]
J.D. Urschel.
Esophagogastrostomy anastomotic leaks complicating esophagectomy: a review.
Am J Surg, 169 (1995), pp. 634-640
[11.]
P. Luechakiettisak, S. Kasetsunthom.
Comparison of hand-sewn and stapled in esophagogastric anastomosis after esophageal cancer resection: a prospective randomized study.
J Med Assoc Thai, 91 (2008), pp. 681-685
[12.]
W. Schröder, A. Hölscher, M. Bludau, D. Vallböhmer, E. Bollschweiler, C. Gutschow.
Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit.
World J Surg, 34 (2010), pp. 738-743
[13.]
S. Law, M. Fok, K.M. Chu, J. Wong.
Comparison of Hand-Sewn and Stapled Esophagogastric Anastomosis After Esophageal Resection for Cancer.
Ann Surg, 226 (1997), pp. 169-173
[14.]
A.I. Sarela, D.J. Tolan, K. Harris, S.P. Dexter, H.M. Sue-Ling.
Anastomotic leakage after esophagectomy for cancer: a mortality-free experience.
J Am Coll Surg, 206 (2008), pp. 516-523
[15.]
M. Al-Sarraf, K. Martz, A. Herskovic, L. Leichman, J.S. Brindle, V.K. Vaitkevicius, et al.
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.
J Clin Oncol, 15 (1997), pp. 277-284
[16.]
V. Munitiz, L.F. Martinez-de-Haro, A. Ortiz, D. Ruiz-de-Angulo, P. Pastor, P. Parrilla.
Effectiveness of a written clinical pathway for enhanced recovery after transthoracic (Ivor Lewis) oesophagectomy.
Br J Surg, 97 (2010), pp. 714-718
[17.]
J. Roig-García, J. Gironés-Vilà, E. Garsot-Savall, M. Puig-Costa, J. Rodríguez-Hermosa, A. Codina-Cazador.
Esofagectomía transtorácica y transhiatal mediante técnicas mínimamente invasivas. Experiencia en 50 pacientes.
Cir Esp, 83 (2008), pp. 180-185
[18.]
V. Munitiz, A. Ortiz-Escandell, L.F. Martínez-de-Haro, J.A. García- Marcilla, J. Molina, D. Ruiz-de-Angulo, et al.
Resultados del cáncer de esófago resecado Estudio comparativo entre el adenocarcinoma y el carcinoma epidermoide.
Cir Esp, 76 (2004), pp. 94-100
[19.]
B.P. Whooley, S. Law, S.C. Murthy, A. Alexandrou, J. Wong.
Analysis of reduced death and complication rates after esophageal resection.
Ann Surg, 233 (2001), pp. 338-344
[20.]
R.C. Connors, B.C. Reuben, L.A. Neumayer, D.A. Bull.
Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17.395 patients.
J Am Coll Surg, 205 (2007), pp. 735-740
[21.]
R.J. Cerfolio, A.S. Bryant, C.S. Bass, J.R. Alexander, A.A. Bartolucci.
Fast tracking after Ivor Lewis esophagogastrectomy.
Chest, 126 (2004), pp. 1187-1194
[22.]
M.W.J.M. Wouters, H.E. Karim-Kos, S. Le Cessie, B.P.L. Wijnhoven, L.P.S. Stassen, W.H. Steup, et al.
Centralization of esophageal cancer surgery: does it improve clinical outcome?.
Ann Surg, 16 (2009), pp. 1789-1798
[23.]
B.P. Whooley, S. Law, A. Alexandrou, S.C. Murthy, J. Wong.
Critical appraisal of the significance of intrathoracic anastomotic leakage after esophagectomy for cancer.
Am J Surg, 181 (2001), pp. 198-203
[24.]
S.M. Griffin, P.J. Lamb, S.M. Dresner, D.L. Richardson, N. Hayes.
Diagnosis and management of a mediastinal leak following radical oesophagectomy.
Br J Surg, 88 (2001), pp. 1346-1351
[25.]
A. Sauvanet, J. Baltar, J. Le Mee, J. Belghiti.
Diagnosis and conservative management of intrathoracic leakage after oesophagectomy.
Br J Surg, 85 (1998), pp. 1446-1449
[26.]
J.W. Briel, A.P. Tamhankar, J.A. Hagen, S.R. DeMeester, J. Johansson, E. Choustoulakis, et al.
Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition.
J Am Coll Surg, 198 (2004), pp. 536-542
[27.]
S.G. Swisher, P. Wynn, J.B. Putnam, M.B. Mosheim, A.M. Correa, R.R. Komaki, et al.
Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy.
J Thorac Cardiovasc Surg, 123 (2002), pp. 175-183
[28.]
F. Fiorica, D. Di Bona, F. Schepis, A. Licata, L. Shahied, A. Venturi, et al.
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.
Gut, 53 (2004), pp. 925-930
[29.]
R.C. Karl, R. Schreiber, D. Boulware, S. Baker, D. Coppola.
Factors affecting morbidity, mortality and survival in patients undergoing Ivor Lewis esophagogastrectomy.
Ann Surg, 231 (2000), pp. 635-643
[30.]
S. Akiyama, Y. Kodera, H. Sekiguchi, Y. Kasai, K. Kondo, I. Katsuki, et al.
Preoperative embolization therapy for esophageal operation.
J Surg Oncol, 69 (1998), pp. 219-223
[31.]
K.M. Reavis, E.Y. Chang, J.G. Hunter, A.J. Blair.
Utilization of the delay phenomenon improves blood flow and reduces collagen deposition in esophagogastric anastomoses.
Ann Surg, 241 (2005), pp. 736-747
[32.]
A.H. Hölscher, P.M. Schneider, C. Gutschow, W. Schröder.
Laparoscopic ischemic conditioning of the stomach for esophageal replacement.
[33.]
R.D. Page, M.J. Shackcloth, G.N. Russell, S.H. Pennefather.
Surgical treatment of anastomotic leaks after oesophagectomy.
Eur J Cardiothorac Surg, 27 (2005), pp. 337-343
[34.]
J.O. Swanson, M.S. Levine, R.O. Redfern, S.E. Rubesin.
Usefulness of high-density barium for detection of leaks after esophagogastrectomy, total gastrectomy, and laryngectomy.
[35.]
C. Strauss, F. Mal, T. Perniceri, N. Bouzar, S. Lenoir, B. Gayet, et al.
Computed tomography versus water-soluble contrast swallow in the detection of intrathoracic anastomotic leak complicating esophagogastrectomy (Ivor Lewis). A prospective study in 97 patients.
Ann Surg, 251 (2010), pp. 647-651
[36.]
J.A. Crestanello, C. Deschamps, S.D. Cassivi, F.C. Nichols, M. Allen, C. Schleck, et al.
Selective management of intrathoracic anastomotic leak after esophagectomy.
J Thorac Cardiovasc Surg, 129 (2005), pp. 254-260
[37.]
S.M. Griffin, I.H. Shaw, S.M. Dresner.
Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: risk factors and management.
J Am Coll Surg, 194 (2002), pp. 285-297
[38.]
H.U. Zieren, J.M. Müller, H. Pichlmaier.
Prospective randomized study of one or two layer anastomosis following oesophageal resection and cervical oesophagogastrostomy.
Br J Surg, 80 (1993), pp. 608-611
[39.]
J.M.T. Omloo, S.M. Lagarde, J.B.F. Hulscher, J.B. Reitsma, P. Fockens, H. Van Dekken, et al.
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus. Five-year survival of a randomized clinical trial.
Ann Surg, 246 (2007), pp. 992-1001
[40.]
A.L. Visbal, M.S. Allen, D.L. Miller, C. Deschamps, V.F. Trastek, P.C. Pairolero.
Ivor Lewis esophagogastrectomy for esophageal cancer.
Ann Thorac Surg, 71 (2001), pp. 1803-1808
[41.]
J.R. Siewert, H.J. Stein, M. Feith, B.L.D.M. Bruecher, H. Bartels, U. Fink.
Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the Western World.
Ann Surg, 234 (2001), pp. 360-369
Copyright © 2011. Asociación Española de Cirujanos
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos